These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37663879)
1. The impact of pulmonary cachexia on inpatient outcomes: A national study. Alahmad MAM; Gibson CA Ann Thorac Med; 2023; 18(3):156-161. PubMed ID: 37663879 [TBL] [Abstract][Full Text] [Related]
2. Inpatient Outcomes for Myocarditis-Related Heart Failure. Alabbas M; Gibson C; Morad A; Mohammad Alahmad MA Avicenna J Med; 2023 Oct; 13(4):237-246. PubMed ID: 38144914 [No Abstract] [Full Text] [Related]
3. Cachexia Is Associated With Adverse Outcomes in Patients Admitted With Heart Failure. Mohamad Alahmad MA; Acharya P; Gibson CA; Wiley M; Hockstad E; Gupta K Am J Cardiol; 2023 Jan; 186():30-35. PubMed ID: 36343443 [TBL] [Abstract][Full Text] [Related]
4. Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease. Slade D; Ray R; Moretz C; Germain G; Laliberté F; Shen Q; Duh MS; MacKnight SD; Hahn B Pulm Ther; 2021 Jun; 7(1):203-219. PubMed ID: 33728597 [TBL] [Abstract][Full Text] [Related]
5. Diabetes associated with higher health care utilization and poor outcomes after COPD-related hospitalizations. Belligund P; Attaway A; Lopez R; Damania D; Hatipoğlu U; Zein JG Am J Manag Care; 2022 Sep; 28(9):e325-e332. PubMed ID: 36121364 [TBL] [Abstract][Full Text] [Related]
6. One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA. Arthur ST; Noone JM; Van Doren BA; Roy D; Blanchette CM Drugs Context; 2014; 3():212265. PubMed ID: 25126097 [TBL] [Abstract][Full Text] [Related]
7. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study. Naito T; Okayama T; Aoyama T; Ohashi T; Masuda Y; Kimura M; Shiozaki H; Murakami H; Kenmotsu H; Taira T; Ono A; Wakuda K; Imai H; Oyakawa T; Ishii T; Omori S; Nakashima K; Endo M; Omae K; Mori K; Yamamoto N; Tanuma A; Takahashi T BMC Cancer; 2017 Nov; 17(1):800. PubMed ID: 29183277 [TBL] [Abstract][Full Text] [Related]
8. Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014. Jiang X; Xiao H; Segal R; Mobley WC; Park H Clin Ther; 2018 Apr; 40(4):613-626.e1. PubMed ID: 29609879 [TBL] [Abstract][Full Text] [Related]
9. Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers. Singer D; Bengtson LGS; Elliott C; Buikema AR; Franchino-Elder J Int J Chron Obstruct Pulmon Dis; 2020; 15():3239-3250. PubMed ID: 33324047 [TBL] [Abstract][Full Text] [Related]
10. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119 [TBL] [Abstract][Full Text] [Related]
11. U.K. National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations. Myint PK; Lowe D; Stone RA; Buckingham RJ; Roberts CM Respiration; 2011; 82(4):320-7. PubMed ID: 21597277 [TBL] [Abstract][Full Text] [Related]
12. The Impact of COPD on in-Hospital Outcomes in Patients with Takotsubo Cardiomyopathy. Li P; Lu X; Teng C; Cai P; Kranis M; Dai Q; Wang B Int J Chron Obstruct Pulmon Dis; 2020; 15():2333-2341. PubMed ID: 33061351 [TBL] [Abstract][Full Text] [Related]
13. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement. Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790 [TBL] [Abstract][Full Text] [Related]
14. Readmissions following an initial hospitalization by COPD exacerbation in Spain from 2006 to 2012. de Miguel-Díez J; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Puente Maestu L; Ramírez García L; López de Andrés A Respirology; 2016 Apr; 21(3):489-96. PubMed ID: 26648085 [TBL] [Abstract][Full Text] [Related]
15. Impact of chronic obstructive pulmonary disease on patients undergoing laryngectomy for laryngeal cancer. Sylvester MJ; Marchiano E; Park RC; Baredes S; Eloy JA Laryngoscope; 2017 Feb; 127(2):417-423. PubMed ID: 27239012 [TBL] [Abstract][Full Text] [Related]
16. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. Ni H; Aye SZ; Naing C Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126 [TBL] [Abstract][Full Text] [Related]
17. Risk assessment of readmissions following an initial COPD-related hospitalization. Baker CL; Zou KH; Su J Int J Chron Obstruct Pulmon Dis; 2013; 8():551-9. PubMed ID: 24348031 [TBL] [Abstract][Full Text] [Related]
18. Chronic obstructive pulmonary disease: hospital and intensive care unit outcomes in the Kingdom of Saudi Arabia. Alaithan AM; Memon JI; Rehmani RS; Qureshi AA; Salam A Int J Chron Obstruct Pulmon Dis; 2012; 7():819-23. PubMed ID: 23269866 [TBL] [Abstract][Full Text] [Related]